Optimal dose of benzathine penicillin G for the treatment of early syphilis in HIV-infected patients in the era of combination antiretroviral therapy
Journal
Clinical Infectious Diseases
Journal Volume
60
Journal Issue
9
Pages
1443-1444
Date Issued
2015
Author(s)
SDGs
Other Subjects
antiretrovirus agent; benzathine penicillin; antitreponemal agent; benzathine penicillin; antibiotic therapy; cohort analysis; disease course; high risk population; human; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; Letter; major clinical study; multicenter study (topic); optimal drug dose; priority journal; prospective study; reinfection; repeated drug dose; serology; sexually transmitted disease; single drug dose; syphilis; treatment failure; treatment response; complication; female; Human immunodeficiency virus infection; male; syphilis; Antitreponemal Agents; Female; HIV Infections; Humans; Male; Penicillin G Benzathine; Syphilis
Publisher
Oxford University Press
Type
letter